OncoSec Granted Exclusive Worldwide Rights To A Patent Portfolio For The Combination Use Of IL-12 DNA With Checkpoint Inhibitors To Treat Cancer In Several Key Countries
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.